Lymphedema Treatment Act

Bill 117 HR 3630, also known as the Lymphedema Treatment Act, is a piece of legislation currently being considered by the US Congress. The bill aims to improve access to treatment for individuals suffering from lymphedema, a chronic condition characterized by swelling in the arms or legs due to a blockage in the lymphatic system.

The Lymphedema Treatment Act proposes to amend Medicare coverage to include compression garments, bandages, and supplies necessary for the treatment of lymphedema. These items are currently not covered by Medicare, making it difficult for many individuals to afford the necessary treatment for their condition.

The bill has received bipartisan support in Congress, with lawmakers recognizing the importance of ensuring that individuals with lymphedema have access to the care they need to manage their condition effectively. Supporters of the bill argue that providing coverage for compression garments and other necessary supplies will ultimately save money by preventing more serious health complications that can arise from untreated lymphedema. If passed, the Lymphedema Treatment Act has the potential to significantly improve the quality of life for individuals living with lymphedema by making essential treatment more affordable and accessible. The bill is currently in the early stages of the legislative process, but it has already garnered attention and support from advocacy groups and healthcare professionals who are eager to see it become law.